FAP and cancer: Quinolone-based FAP inhibitors (FAPIs) have been successfully applied to PET imaging in various cancers, providing advantages over conventional 18F-FDG PET/CT in several tumor entities for the initial staging and detection of tumor recurrence and metastases (Pang et al. 2021).